Trxade Health Inc (MEDS) stock is lower by -78.17% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives MEDS stock a score of 30 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 0. MEDS's rank also includes a long-term technical score of 6. MEDS has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on MEDS!